Osaic Holdings
CCCC icon

Osaic Holdings’s C4 Therapeutics CCCC Stock Holding History

Osaic Holdings’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.9K Hold
4,544
– – ﹤0.01% 6190
2025
Q4 		$8.68K Buy
4,544
+14
+0.3% +$33 ﹤0.01% 6429
2025
Q3 		$11.3K Buy
4,530
+3,030
+202% +$7.27K ﹤0.01% 6290
2025
Q2 		$2.15K Buy
+1,500
New +$2.18K ﹤0.01% 6913
2024
Q4 		– Sell
-530
Closed -$3.02K – 7432
2024
Q3 		$3.02K Buy
+530
New +$3.19K ﹤0.01% 6436
2023
Q4 		– Sell
-1,000
Closed -$1.86K – 7317
2023
Q3 		$1.86K Buy
+1,000
New +$3.05K ﹤0.01% 6655
2023
Q1 		– Sell
-185
Closed -$1K – 7505
2022
Q4 		$1K Buy
+185
New +$1.53K ﹤0.01% 6845

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings's CCCC Position: Q1 2026 in Review

Osaic Holdings held its C4 Therapeutics (CCCC) position steady in Q1 2026 at 4,544 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6190.

Osaic Holdings first reported a position in CCCC in Q4 2022 and has held it in 7 quarters since. 123 funds tracked by Wall St. Rank hold CCCC as of Q1 2026.

  • Osaic Holdings held 4,544 shares of C4 Therapeutics worth $11.9K as of Q1 2026.
  • Osaic Holdings left its C4 Therapeutics share count unchanged in Q1 2026.
  • C4 Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6190 holding.
  • Osaic Holdings first reported a position in C4 Therapeutics in Q4 2022 and has held it in 7 quarters since.
  • 123 funds tracked by Wall St. Rank held C4 Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.